Incidence and Prevalence of Pulmonary Tuberculosis Among Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2022 Jun 15

PMID 35703920

Authors

Qian Wu

Yang Liu

Yu-Bo Ma

Kui Liu

Song-Hua Chen

Affiliations

Soon will be listed here.

Abstract

Background: The epidemic of type 2 diabetes mellitus (T2DM) poses a great challenge to pulmonary tuberculosis (PTB) control. However, the incidence and prevalence of PTB among T2DM patients has not been fully determined. This meta-analysis aimed to provide the estimation on the global incidence and prevalence of PTB among T2DM patients (T2DM-PTB).

Methods: Online databases including Web of Science, PubMed, China National Knowledge Infrastructure and Cochrane Library were searched for all relevant studies that reported the incidence or prevalence of T2DM-PTB through 31 January 2022. Pooled incidence and prevalence of T2DM-PTB with 95% confidence interval (CI) was estimated by the random-effect model. All statistical analyses were performed using R software.

Results: A total of 24 studies (14 cohort studies, 10 cross-sectional studies) were included. The pooled incidence and prevalence of T2DM-PTB were 129.89 per 100,000 person-years (95% confidence interval (CI): 97.55-172.95) and 511.19 per 100,000 (95% CI: 375.94-695.09), respectively. Subgroup analyses identified that the incidence of T2DM-PTB was significantly higher in Asia (187.20 per 100,000 person-years, 95% CI: 147.76-237.17), in countries with a high TB burden (172.04 per 100,000 person-years, 95% CI: 122.98-240.68) and in studies whose data collection ended before 2011 (219.81 per 100,000 person-years, 95% CI: 176.15-274.28), but lower in studies using International Classification of Diseases-10 codes (73.75 per 100,000 person-years, 95% CI: 40.92-132.91). The prevalence of T2DM-PTB was significantly higher in countries with a high TB burden (692.15 per 100,000, 95% CI: 468.75-1022.04), but lower in Europe (105.01 per 100,000, 95% CI: 72.55-151.98).

Conclusions: This systematic review and meta-analysis suggests high global incidence and prevalence of PTB among T2DM patients, underlining the necessity of more preventive interventions among T2DM patients especially in countries with a high TB-burden. Key messagesA total of 24 studies (14 cohort studies, 10 cross-sectional studies) containing 2,569,451 T2DM patients were included in this meta-analysis.The pooled incidence and prevalence of T2DM-PTB are 129.89 per 100,000 person-years (95% CI: 97.55-172.95) and 511.19 per 100,000 (95% CI: 375.94-695.09) respectively.The incidence of T2DM-PTB was significantly higher in Asia, in countries with a high TB burden and in studies whose data collection ended before 2011, but lower in studies using International Classification of Diseases-10 codes.The prevalence of T2DM-PTB was significantly higher in countries with a high TB-burden, but lower in Europe.

Citing Articles

Causal relationship between type 2 diabetes and common respiratory system diseases: a two-sample Mendelian randomization analysis.

Chen J, Zhang X, Sun G Front Med (Lausanne). 2024; 11:1332664.

PMID: 39091286 PMC: 11291206. DOI: 10.3389/fmed.2024.1332664.

Diagnostic accuracy of nanopore sequencing for the rapid diagnosis of pulmonary tuberculosis: A protocol for a systematic review and meta-analysis.

Yu G, Xu X, Shen Y, Fang B PLoS One. 2024; 19(6):e0304162.

PMID: 38843269 PMC: 11156269. DOI: 10.1371/journal.pone.0304162.

Prevalence and Risk Factors of Diabetes in Patients with Active Pulmonary Tuberculosis: A Cross-Sectional Study in Two Financially Affluent China Cities.

Li J, Zhao Y, Jiang Y, Zhang Y, Zhang P, Shen L Diabetes Metab Syndr Obes. 2024; 17:1105-1114.

PMID: 38450415 PMC: 10916512. DOI: 10.2147/DMSO.S450507.

Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.

Zhao L, Fan K, Sun X, Li W, Qin F, Shi L Front Immunol. 2024; 14:1305325.

PMID: 38259491 PMC: 10800548. DOI: 10.3389/fimmu.2023.1305325.

Comorbidity increases the risk of pulmonary tuberculosis: a nested case-control study using multi-source big data.

Wang B, Song K, Wang H, Wang S, Wang W, Li Z BMC Pulm Med. 2024; 24(1):29.

PMID: 38212743 PMC: 10782630. DOI: 10.1186/s12890-023-02817-6.

References

Wang Y, Dou M, Kou T, Liu Y, Lv W, Han L . Risk of having pulmonary tuberculosis in type 2 diabetes: A hospital-based matched case-control study. Asia Pac J Clin Nutr. 2021; 30(2):303-310. DOI: 10.6133/apjcn.202106_30(2).0015. View

Ekeke N, Aniwada E, Chukwu J, Nwafor C, Meka A, Chukwuka A . Screening diabetes mellitus patients for tuberculosis in Southern Nigeria: A pilot study. Adv Respir Med. 2020; 88(1):6-12. DOI: 10.5603/ARM.2020.0072. View

Kang Y, Choi N, Seong J, Heo E, Koo B, Hwang S . The effects of statin use on the development of tuberculosis among patients with diabetes mellitus. Int J Tuberc Lung Dis. 2014; 18(6):717-24. DOI: 10.5588/ijtld.13.0854. View

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

Al-Rifai R, Pearson F, Critchley J, Abu-Raddad L . Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One. 2017; 12(11):e0187967. PMC: 5697825. DOI: 10.1371/journal.pone.0187967. View

Gadallah M, Abdelmoniem W, Fawzy M, Mokhtar A, Mohsen A . Multicenter screening of diabetic patients for detecting new cases of tuberculosis: an approach to intensify the case detection rate of tuberculosis in developing countries with high prevalence of diabetes. J Prev Med Hyg. 2020; 60(4):E343-E348. PMC: 6953452. DOI: 10.15167/2421-4248/jpmh2019.60.4.883. View

Lin S, Tu H, Lu P, Chen T, Wang W, Chong I . Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes. Respirology. 2018; 23(11):1063-1073. DOI: 10.1111/resp.13338. View

Borenstein M, Hedges L, Higgins J, Rothstein H . A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2015; 1(2):97-111. DOI: 10.1002/jrsm.12. View

Ji Y, Cao H, Liu Q, Li Z, Song H, Xu D . Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis. 2020; 93:84-89. DOI: 10.1016/j.ijid.2020.01.019. View

10.

Pealing L, Wing K, Mathur R, Prieto-Merino D, Smeeth L, Moore D . Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMC Med. 2015; 13:135. PMC: 4470065. DOI: 10.1186/s12916-015-0381-9. View

11.

Chen Z, Liu Q, Song R, Zhang W, Wang T, Lian Z . The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocr Disord. 2021; 21(1):123. PMC: 8207612. DOI: 10.1186/s12902-021-00779-6. View

12.

Workneh M, Bjune G, Yimer S . Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017; 12(4):e0175925. PMC: 5400500. DOI: 10.1371/journal.pone.0175925. View

13.

Wagnew F, Eshetie S, Alebel A, Dessie G, Tesema C, Abajobir A . Meta-analysis of the prevalence of tuberculosis in diabetic patients and its association with cigarette smoking in African and Asian countries. BMC Res Notes. 2018; 11(1):298. PMC: 5952828. DOI: 10.1186/s13104-018-3390-x. View

14.

Dabhi P, Thangakunam B, Gupta R, James P, Thomas N, Naik D . Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital. PLoS One. 2020; 15(6):e0233385. PMC: 7274437. DOI: 10.1371/journal.pone.0233385. View

15.

Leung C, Lam T, Chan W, Yew W, Ho K, Leung G . Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol. 2008; 167(12):1486-94. DOI: 10.1093/aje/kwn075. View

16.

Dooley K, Chaisson R . Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009; 9(12):737-46. PMC: 2945809. DOI: 10.1016/S1473-3099(09)70282-8. View

17.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

18.

Heo E, Choi N, Yang B, Koo B, Hwang S, Lee C . Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus. Int J Tuberc Lung Dis. 2015; 19(9):1098-101. DOI: 10.5588/ijtld.14.0772. View

19.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

20.

Lee M, Lin K, Hsu W, Chang H, Yang Y, Hsiao P . Statin, calcium channel blocker and Beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes. Int J Mol Sci. 2015; 16(5):11369-84. PMC: 4463705. DOI: 10.3390/ijms160511369. View